Tirzepatide is a glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Not everyone benefits from split dosing, and single morning administration works well for many users
DSIP's research base spans nearly five decades
However, this study examined only the effects of lipotropic substances in the rats diet, not lipotropic injections, and has limitations as an animal study
B12 injections are a powerful way to boost your energy and improve overall health
International Journal of Toxicology (2014) 11